Image by Getty Images via Daylife
After Barack Obama’s victory in the U.S. presidential elections, the economic community, in the middle of a recession and the worst financial crisis in the past decades, continues to hold its breath. The Democrat’s victory induce change and potentially more difficult times for the energy, pharmaceutical, telecommunications, and defense sectors, while the biotechnology and alternative energy sectors could be strengthened by the outcome of the elections. Obama has promised to increase investments in wind and solar energy and to spend 150 billion dollars in 10 years to hasten the development of
Image via Wikipedia
A new therapy based on embryonic stem cells will give a new hope to people who did lose their ability to move in some accident. But that’s not all, because this therapy, developed by the Geron Corp., is the demonstration that in USA, since a few days from Obama‘s election, a new course in research – above all in stem cells research – has begun.
The Food and Drug Administration (FDA) frees the medics to inject spinal stem cells extracted from embryonic tissue in legs paralysed patients since a short time. The treatment in on experimental phase, but
SANTIAGO, Dominican Republic (CNN) — This Caribbean city already known for cigars, furniture, chocolate and coffee may become a magnet for Americans seeking controversial stem cell therapy for life-threatening illnesses if a Florida cardiologist has his way.
The Food and Drug Administration has not approved this stem cell therapy in the United States because no clinical trials to prove its effectiveness have been done. But Dr. Zannos Grekos says his company, Regenocyte Therapeutic, has successfully used adult stem cells to treat patients with heart and lung disease.
Grekos said he and his associates draw blood from a patient in Florida and
In a couple of months, the first test to verify if embryonic stem cells directly injected inside patients’ brain plagued by stroke can regenerate damaged areas, will start in Scotland.
A team from Southern General Hospital of Glasgow selected 4 groups of 3 patients that will be treated during the next 2 years.
Firstly patients will take a dose of 2 millions embryonic stem cells. The amount will be gradually increased to 20 millions of stem cells, which is what doctors think patients need to start the re-creating processes.
Stem Cell Research Trials for Heart Attacks and Heart Failure
Recent stem cell research studies using Adult Stem Cells to treat heart diseases such as congestive heart failure and heart attacks have made the news recently. And on the surface, these adult stem cell success stories of heart attack victims making amazing recoveries in these research […]